JACOB GALLAHER: Open Payments
NPI 1063006922 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,994 in 112 payments from 25 companies in 2025. Trend: 2023 $1,535 · 2024 $1,931 · 2025 $1,994
Food & beverage: $1,994
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $662 |
| Novartis Pharmaceuticals Corporation | 12 | $228 |
| Janssen Biotech, Inc. | 5 | $203 |
| Medtronic, Inc. | 2 | $126 |
| Novo Nordisk Inc | 5 | $91 |
| Xeris Pharmaceuticals, Inc. | 4 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Abbott Laboratories | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: RINVOQ, TREMFYA, LEQVIO, MINIMED 780G, CREON, LINZESS, GVOKE HYPOPEN, INGREZZA.
Industry payments across TN — which companies pay providers there.
